Nishadil
Signup Signin
Delhi | 25°C (windy)
CRISPR Therapeutics: Beyond the Hype, A Foundational Investment in Gene Editing's Future

CRISPR Therapeutics: Beyond the Hype, A Foundational Investment in Gene Editing's Future
A New Challenger Emerges: Could Viridian's Eye Disease Drug Outshine Amgen's Blockbuster Tepezza?

A New Challenger Emerges: Could Viridian's Eye Disease Drug Outshine Amgen's Blockbuster Tepezza?
Unearthing Value: Goldman's Guide to S&P 500 Stocks Flying Under the Hedge Fund Radar

Unearthing Value: Goldman's Guide to S&P 500 Stocks Flying Under the Hedge Fund Radar
Beyond the Old Playbook: Crafting a Resilient Portfolio for Today's Unpredictable Markets

Beyond the Old Playbook: Crafting a Resilient Portfolio for Today's Unpredictable Markets
Marjorie Taylor Greene Hints at Congressional Exit for Potential Trump VP Slot

Marjorie Taylor Greene Hints at Congressional Exit for Potential Trump VP Slot
Unlocking Value in Healthcare: A Prudent Path to S&P 500 Dividends

Unlocking Value in Healthcare: A Prudent Path to S&P 500 Dividends
A Seismic Shift? Unpacking RFK Jr.'s Radical Vision for America's Top Health Regulator

A Seismic Shift? Unpacking RFK Jr.'s Radical Vision for America's Top Health Regulator
FDA Approves Tezspire Self-Administration, Revolutionizing Severe Asthma Care for Amgen and AstraZeneca

FDA Approves Tezspire Self-Administration, Revolutionizing Severe Asthma Care for Amgen and AstraZeneca
Tariff Relief: US Postpones Duties on Singaporean Pharma Amidst Supply Chain Concerns

Tariff Relief: US Postpones Duties on Singaporean Pharma Amidst Supply Chain Concerns
The Biotech Bonanza: Unearthing Tomorrow's Investment Gems in a Volatile Market

The Biotech Bonanza: Unearthing Tomorrow's Investment Gems in a Volatile Market
Unlock Financial Freedom: Crafting Your $500,000 Low-Stress Retirement Portfolio for Lasting Peace of Mind

Unlock Financial Freedom: Crafting Your $500,000 Low-Stress Retirement Portfolio for Lasting Peace of Mind
A Pivotal Moment: HHS Advances Major Drug Pricing Rule for Review

A Pivotal Moment: HHS Advances Major Drug Pricing Rule for Review
Unleash the Alpha: Why This October Dog of the Dow is a Top Dividend Pick

Unleash the Alpha: Why This October Dog of the Dow is a Top Dividend Pick
Trump's Bold Play: Delaying Pharma Tariffs for Deeper Drug Price Deals

Trump's Bold Play: Delaying Pharma Tariffs for Deeper Drug Price Deals
Trump's Bold Vision: Pushing for Direct Drug Deals to Slash Costs

Trump's Bold Vision: Pushing for Direct Drug Deals to Slash Costs
Unearthing Hidden Gems: The Top 30 Most Undervalued S&P 500 Stocks for Astute Investors

Unearthing Hidden Gems: The Top 30 Most Undervalued S&P 500 Stocks for Astute Investors
Historic Shift: White House Reviews Landmark Drug Price Negotiation Rule

Historic Shift: White House Reviews Landmark Drug Price Negotiation Rule
European Experts Back Two AstraZeneca Breakthroughs: New Hope for Rare Diseases

European Experts Back Two AstraZeneca Breakthroughs: New Hope for Rare Diseases
Affiliated Managers Group: Unlocking Value and Safety with Strategic "Baby Bonds"

Affiliated Managers Group: Unlocking Value and Safety with Strategic "Baby Bonds"
The Next Battleground: Novo Nordisk and Eli Lilly's Hundred-Year War for Oral GLP-1 Dominance

The Next Battleground: Novo Nordisk and Eli Lilly's Hundred-Year War for Oral GLP-1 Dominance
Metsera: The New Power Player Set to Disrupt the $100 Billion GLP-1 Market

Metsera: The New Power Player Set to Disrupt the $100 Billion GLP-1 Market
A Major Setback for Amgen: Bemarituzumab's Gastric Cancer Ambitions Dim as Final Data Fails to Impress

A Major Setback for Amgen: Bemarituzumab's Gastric Cancer Ambitions Dim as Final Data Fails to Impress
Sanofi Stock Plunges as Zantac Lawsuit Risks Re-Emerge Following Key Judicial Ruling

Sanofi Stock Plunges as Zantac Lawsuit Risks Re-Emerge Following Key Judicial Ruling
Load more..